Barclays initiated coverage on Tenet Healthcare with a new price target
$THC
Hospital/Nursing Management
Health Care
Barclays initiated coverage of Tenet Healthcare with a rating of Overweight and set a new price target of $113.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2025 | $175.00 | Buy | TD Cowen |
| 12/17/2024 | $175.00 | Overweight | Analyst |
| 12/16/2024 | $196.00 → $140.00 | Buy → Neutral | Goldman |
| 11/25/2024 | $205.00 → $150.00 | Overweight → Equal Weight | Wells Fargo |
| 11/22/2024 | $195.00 | Strong Buy → Outperform | Raymond James |
| 10/11/2024 | $200.00 | Overweight | KeyBanc Capital Markets |
| 5/30/2024 | $153.00 | Outperform | Robert W. Baird |
| 3/27/2024 | $122.00 | Peer Perform → Outperform | Wolfe Research |
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
TD Cowen initiated coverage of Tenet Healthcare with a rating of Buy and set a new price target of $175.00
Analyst resumed coverage of Tenet Healthcare with a rating of Overweight and set a new price target of $175.00
Goldman downgraded Tenet Healthcare from Buy to Neutral and set a new price target of $140.00 from $196.00 previously
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G - TENET HEALTHCARE CORP (0000070318) (Subject)
Tenet Healthcare Corporation (NYSE:THC) will release its fourth quarter 2024 results before the market opens on Wednesday, February 12, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospital
Tenet Healthcare Corporation (NYSE:THC) will release its third quarter 2024 results before the market opens on Tuesday, October 29, 2024, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We a
Tenet Healthcare Corporation (NYSE:THC) will release its second quarter 2024 results on Wednesday, July 24, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and su
Tenet Healthcare Corporation (NYSE:THC) is scheduled to present virtually at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2024, beginning at 10:00 a.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers
Net income available to common shareholders in fourth quarter 2024 was $318 million, or $3.32 per diluted share Adjusted diluted earnings per share1 was $3.44 in fourth quarter 2024 Consolidated Adjusted EBITDA1 in fourth quarter 2024 was $1.048 billion, which represents an Adjusted EBITDA margin of 20.7% Fourth quarter 2024 Ambulatory Care Adjusted EBITDA of $530 million increased 14.2% over fourth quarter 2023 FY 2025 Adjusted EBITDA Outlook is expected to be in the range of $3.975 billion to $4.175 billion Tenet Healthcare Corporation (Tenet) (NYSE:THC) today announced its results for the quarter ended December 31, 2024. "2024 was an outstanding year for Tenet character
Tenet Healthcare Corporation (NYSE:THC) will release its fourth quarter 2024 results before the market opens on Wednesday, February 12, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospital
10-K - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Vineeta Agarwala, M.D., PhD, to its Board of Directors, effective immediately. Dr. Agarwala will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee, increasing the size of the Board to 13 directors. "We are pleased to welcome Dr. Vineeta Agarwala to the Tenet Board," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Vineeta is a leader in healthcare in her own right. Her expertise in innovative technologies, including applications of artificial intelligence will enhance our governance in a rapidly evolving healthcare marketplace." Dr
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Senator Roy Blunt to the Tenet Board of Directors, effective immediately. Senator Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. This appointment expands the Board to 12 directors, 11 of whom are independent members. "We are pleased to welcome Senator Roy Blunt as a new board member," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. "With more than 25 years of legislative experience, Roy's expertise in public policy and addressing cross-cutting issues will be invaluable to helping Tenet make a lasting
Tenet Healthcare Corporation (NYSE:THC) today announced that its Board of Directors has elected Chief Executive Officer, Saum Sutaria, M.D., to assume the additional position of Chairman, effective immediately. Sutaria succeeds Senator J. Robert Kerrey, who will transition to Lead Director of the Board, a role he previously held from 2017- 2022. Sutaria has served as Tenet Healthcare's CEO since September 2021 and a member of the Board of Directors since 2020. Previously, he served as the Company's Chief Operating Officer. "The appointment of Saum to Chairman is a testament to his steadfast leadership and commitment to Tenet Healthcare," said Senator J. Robert Kerrey, Lead Director. "Th